ARRY
Price
$7.41
Change
-$0.06 (-0.80%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
2.22B
29 days until earnings call
FBRX
Price
$9.86
Change
-$0.69 (-6.54%)
Updated
Jul 14, 04:59 PM (EDT)
Capitalization
128.86M
Interact to see
Advertisement

ARRY vs FBRX

Header iconARRY vs FBRX Comparison
Open Charts ARRY vs FBRXBanner chart's image
Array Technologies
Price$7.41
Change-$0.06 (-0.80%)
Volume$113.5K
Capitalization2.22B
Forte Biosciences
Price$9.86
Change-$0.69 (-6.54%)
Volume$215
Capitalization128.86M
ARRY vs FBRX Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. FBRX commentary
Jul 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Hold and FBRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2025
Stock price -- (FBRX: $10.55)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBRX’s FA Score shows that 0 FA rating(s) are green while.

  • FBRX’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 7 TA indicator(s) are bullish while FBRX’s TA Score has 3 bullish TA indicator(s).

  • ARRY’s TA Score: 7 bullish, 2 bearish.
  • FBRX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than FBRX.

Price Growth

FBRX (@Biotechnology) experienced а -22.77% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +13.15%. For the same industry, the average monthly price growth was +23.60%, and the average quarterly price growth was +32.61%.

Reported Earning Dates

FBRX is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+13.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($2.22B) has a higher market cap than FBRX($129M). ARRY YTD gains are higher at: 23.675 vs. FBRX (-53.545). ARRY has higher annual earnings (EBITDA): 276M vs. FBRX (-44.88M). ARRY has more cash in the bank: 249M vs. FBRX (45.9M). ARRY has higher revenues than FBRX: ARRY (1.58B) vs FBRX (0).
ARRYFBRXARRY / FBRX
Capitalization2.22B129M1,722%
EBITDA276M-44.88M-615%
Gain YTD23.675-53.545-44%
P/E Ratio26.23N/A-
Revenue1.58B0-
Total Cash249M45.9M542%
Total Debt730MN/A-
FUNDAMENTALS RATINGS
ARRY vs FBRX: Fundamental Ratings
ARRY
FBRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4451
P/E GROWTH RATING
1..100
2752
SEASONALITY SCORE
1..100
66n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRY's Valuation (89) in the Biotechnology industry is in the same range as FBRX (98) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

ARRY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's SMR Rating (99) in the null industry is in the same range as ARRY (100) in the Biotechnology industry. This means that FBRX’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's Price Growth Rating (44) in the Biotechnology industry is in the same range as FBRX (51) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

ARRY's P/E Growth Rating (27) in the Biotechnology industry is in the same range as FBRX (52) in the null industry. This means that ARRY’s stock grew similarly to FBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYFBRX
RSI
ODDS (%)
Bullish Trend 15 days ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 15 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNREX13.750.03
+0.22%
Dunham Real Estate Stock N
JARIX15.170.01
+0.07%
Easterly Global Real Estate I
MMINX13.26-0.04
-0.30%
MM S&P 500® Index R3
OMGCX26.19-0.21
-0.80%
JPMorgan Mid Cap Growth C
PIGWX16.26-0.14
-0.85%
Putnam International Value R6

FBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBRX has been loosely correlated with QSI. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if FBRX jumps, then QSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-7.90%
QSI - FBRX
34%
Loosely correlated
-4.42%
AXON - FBRX
31%
Poorly correlated
-0.46%
ARRY - FBRX
28%
Poorly correlated
-2.23%
CLNN - FBRX
27%
Poorly correlated
-4.52%
CDTX - FBRX
27%
Poorly correlated
-0.68%
More